Ecosystem News

Pathios Awarded Innovate UK Grant to Evaluate Preclinical Brain Tumor Models

Pathios Therapeutics Awarded Innovate UK Grant to Evaluate First-in-Class Immunotherapy Approach in Models of Malignant Brain Cancer Company Collaborating with Researchers at…

ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant

ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers Prestigious Award Provides…

Promising Preclinical Data from Research Collaboration with Immunocore

Grey Wolf Therapeutics Reports Promising Preclinical Data from Research Collaboration with Immunocore in Oral Presentation at the American Association for Cancer Research…

ThirtyFiveBio data debut: AACR 2023 poster presentation

ThirtyFiveBio were delighted to make our data debut at the American Association for Cancer Research (AACR) 2023 conference. CEO, James Westcott, presented…

Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours First-in-Class…

ThirtyFiveBio Stealth Emergence – presentation of first data at AACR23

ThirtyFiveBio emerges from stealth with presentation of first data from GPR35 Antagonist Program at AACR 2023. Third Company Created by M:M Bio and…